查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529674

化學冷光免疫檢測市場規模、佔有率和趨勢分析報告：2024-2030 年按產品、應用、最終用途、地區和細分市場進行的預測

Chemiluminescence Immunoassay Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Sample Type (Blood, Urine), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

化學冷光免疫檢測市場的成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球化學冷光免疫檢測市場規模預計將達到 155 億美元。

預計2024年至2030年複合年成長率為4.6%。慢性病的高盛行率、化學冷光免疫檢測(CLIA) 技術的多項優勢以及新型 CLIA 解決方案的核准和推出預計將成為推動市場的主要因素。

新興市場的主要參與者正在實施有機和無機成長策略來行銷、開拓和銷售新的 CLIA 解決方案。例如，2020 年 2 月，中國免疫測量製造商 Snibe Diagnostic 的新型 MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA套件獲得了 CE 標誌。另一個例子是，2018 年 1 月，DiaSorin 與德國 Qiagen 合作，將 Qiagen 的 QuantiFERON-TB 診斷測試產品組合添加到全自動化學冷光免疫檢測分析儀 LIAISON 系列中。領先公司的這些舉措預計將顯著促進市場成長。然而，自動化化學冷光免疫檢測系統的高設置成本預計將成為限制市場成長的主要因素。

此外，關鍵地區慢性病的高盛行率以及新興國家對這些疾病的認知不斷提高，預計將推動對新診斷解決方案（包括化學冷光免疫檢測）的需求。根據美國癌症協會發布的資料，2020年美國估計新診斷出180萬癌症病例，約606,520人因癌症死亡。此外，根據世界衛生組織2020年11月發布的資料，愛滋病毒已成為全球重大公共衛生議題，全球約有3,790萬人感染愛滋病毒。

化學冷光免疫檢測市場報告亮點

  • 從產品來看，由於治療藥物監測、內分泌和疾病診斷的高需求，耗材將在 2023 年佔據市場主導地位。
  • 從應用來看，2023年感染疾病領域佔最大。這是由於感染疾病的高盛行率以及用於感染疾病診斷的新型 CLIA 檢測方法的推出。
  • 按最終用途分類，由於住院患者數量不斷增加以及慢性病患病率上升，醫院部門在 2020 年和 2023 年佔據最大佔有率。
  • 在北美地區，美國在2023年佔據最大佔有率。這是由於發達的醫療保健基礎設施、技術先進的 CLIA 系統的高採用率以及主要企業的強大地理影響力。
  • 預計亞太地區在預測期內將以最快的複合年成長率擴張。印度和中國等新興市場的本土企業的崛起主要推動了該區域市場的發展。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章化學冷光免疫檢測市場變數、趨勢、範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 化學冷光免疫檢測市場分析工具
    • 波特的分析
    • PESTEL分析

第4章化學冷光免疫檢測市場：按產品估計和趨勢分析

  • 細分儀表板
  • 化學冷光免疫檢測市場：2023 年和 2030 年按產品分類的變異分析
  • 裝置
  • 消耗品
  • 軟體和服務

第5章化學冷光免疫檢測市場：按樣本類型的估計和趨勢分析

  • 細分儀表板
  • 化學冷光免疫檢測市場：2023 年和 2030 年按樣本類型進行的變異分析
  • 血
  • 尿
  • 唾液
  • 其他樣品類型

第6章化學冷光免疫檢測市場：按應用估算和趨勢分析

  • 細分儀表板
  • 化學冷光免疫檢測市場：2023 年和 2030 年按應用分類的變化分析
  • 治療藥物監測
  • 腫瘤學
  • 心臟病學
  • 內分泌學
  • 感染疾病
  • 自體免疫疾病
  • 其他用途

第7章化學冷光免疫檢測市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 化學冷光免疫檢測市場：2023 年和 2030 年最終用途的變化分析
  • 醫院
  • 臨床實驗室
  • 製藥和生物技術公司
  • 其他用途

第8章化學冷光免疫檢測市場：區域估計和趨勢分析

  • 2023 年和 2030 年化學冷光免疫檢測市場佔有率（按地區）
  • 北美洲
    • 2018-2030年北美化學冷光免疫檢測市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲化學冷光免疫檢測市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區化學冷光免疫檢測估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲化學冷光免疫檢測市場估計與預測
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲化學冷光免疫檢測市場估計和預測，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • DiaSorin SpA
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers
    • Ortho Clinical Diagnostics
簡介目錄
Product Code: GVR-4-68039-152-8

Chemiluminescence Immunoassay Market Growth & Trends:

The global chemiluminescence immunoassay market size is expected to reach USD 15.50 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.6% from 2024 to 2030. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.

Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen's QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.

Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness regarding these diseases in emerging economies are anticipated to upsurge the demand for novel diagnostic solutions, including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S. and around 606,520 people died due to the disease. In addition, as per the data published by the WHO in November 2020, HIV emerged as a major global public health issue and around 37.9 million people around the globe were living with the disease.

Chemiluminescence Immunoassay Market Report Highlights:

  • Based on product, consumables dominated the market in 2023 owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
  • In terms of application, the infectious disease segment held the largest share in 2023 owing to the high prevalence of such diseases and the launch of novel CLIA assays for infectious disease diagnosis
  • By end use, in 2020, the hospitals segment accounted for the largest share in 2023 owing to the increasing hospitalizations, along with the rising prevalence of chronic diseases
  • In North America, the U.S. held the largest share in 2023 owing to the developed healthcare infrastructure, the high adoption of technologically advanced CLIA systems, and the strong geographical presence of prominent players
  • Asia Pacific is expected to expand at the fastest CAGR during the forecast period. The emergence of local players in developing markets, such as India and China, is primarily driving the regional market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Chemiluminescence Immunoassay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Chemiluminescence Immunoassay Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Chemiluminescence Immunoassay Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Chemiluminescence Immunoassay Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Automated
      • 4.3.2.1. Automated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Semi-automated
      • 4.3.3.1. Semi-automated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software & Services
    • 4.5.1. Software & Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Chemiluminescence Immunoassay Market: Sample Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Chemiluminescence Immunoassay Market: Sample Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Blood
    • 5.3.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Urine
    • 5.4.1. Urine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Saliva
    • 5.5.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Other Sample Types
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Chemiluminescence Immunoassay Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Chemiluminescence Immunoassay Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Therapeutic Drug Monitoring
    • 6.3.1. Therapeutic Drug Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Cardiology
    • 6.5.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Endocrinology
    • 6.6.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Autoimmune Disease
    • 6.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Other Applications
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Chemiluminescence Immunoassay Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Chemiluminescence Immunoassay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Clinical Laboratories
    • 7.4.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Pharmaceutical & Biotechnology Companies
    • 7.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Other End Uses
    • 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Chemiluminescence Immunoassay Market: Regional Estimates & Trend Analysis

  • 8.1. Chemiluminescence Immunoassay Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Abbott Laboratories
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/Strategic Initiatives
    • 9.4.2. Beckman Coulter Inc.
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/Strategic Initiatives
    • 9.4.3. DiaSorin S.p.A.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/Strategic Initiatives
    • 9.4.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/Strategic Initiatives
    • 9.4.5. F. Hoffmann-La Roche AG
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/Strategic Initiatives
    • 9.4.6. Siemens Healthineers
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/Strategic Initiatives
    • 9.4.7. Ortho Clinical Diagnostics
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/Strategic Initiatives